Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling
Therapeutic Advances in Drug Safety
Published online on March 31, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Psychedelic and psychedelic-adjacent substances, including 3,4-methylenedioxymethamphetamine (MDMA) and classic serotonergic hallucinogens, are undergoing renewed therapeutic investigation and remain in non-medical use. Inadvertent exposure during early, ...
Psychedelic and psychedelic-adjacent substances, including 3,4-methylenedioxymethamphetamine (MDMA) and classic serotonergic hallucinogens, are undergoing renewed therapeutic investigation and remain in non-medical use. Inadvertent exposure during early, ...